Accelerate development and reduce risk with precise, robust biomarker analysis
Multiplexed & quantitative LC-MS proteomics with end-to-end support for drug discovery & industry-leading development
We generate molecular insights that transform drug development and healthcare – bringing clarity and confidence to research with our novel proteomics solutions
Delivering highly accurate, fully quantitative and definitive targeted biomarker analysis to accelerate the successful development of life-changing treatments
The Inoviv Edge
Maximise treatment efficacy and clinical outcomes through Inoviv’s proprietary mass spectrometry workflows
Absolute Quantification using full-length protein standards for robust data
Exceptional Sensitivity down to pg/ml for low-abundance biomarkers
Why MS-based proteomics for targeted workflows?
Proteomics sees all.
How mass spectrometry identifies and quantifies protein abundance
Our in-house bioinformatics team build bespoke workflows to simplify your omics data and guide your decisions to transform discovery proteomics findings into robust, targeted assays, measuring key proteins and streamlining your drug development goals.
Offering real-world solutions, including:
- Mechanistic Insights
- Patient Stratification
- Companion Diagnostics
- Treatment Monitoring
An Elite Team of Proteomics Experts
Our dedicated team brings decades of collective experience and a meticulous devotion to scientific rigor